Samsara BioCapital

Samsara BioCapital Overview

Investor Type Venture Capital
Status Active
Professionals 4
Professionals
Investments 29
Portfolio 18
Exits 10
Exits

Samsara BioCapital General Information

Description

Founded in 2016, Samsara BioCapital is a venture capital firm headquartered in Palo Alto, California. The firm prefers to invest in the life sciences, oncology, and digital healthcare sectors.

Contact Information

Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 628 Middlefield Road
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Samsara BioCapital Investments (29)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bolt Biotherapeutics 01-Jul-2020 Later Stage VC 000.00 Drug Discovery Generating Revenue
000000 000 23-Jun-2020 0000 000.00 Biotechnology Generating Revenue
0000000 0000000000 10-Jun-2020 0000 000.00 Drug Discovery Generating Revenue/Not Profitable
00000000 000000000 09-Jun-2020 00000 00000 0000 Biotechnology Product In Beta Test
00000 000000000 04-Jun-2020 0000 000.00 Drug Discovery Generating Revenue
00000000 000000000 28-May-2020 00000 00000 0000 Biotechnology Clinical Trials - Phase 3 0000 000000000 00.0
0000000000 12-Mar-2020 00000 00000 00000 Biotechnology Startup
00000 000000000000 19-Dec-2019 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable
Levo Therapeutics 22-Nov-2019 Early Stage VC 0000 Biotechnology Clinical Trials - Phase 3
A2 Biotherapeutics 05-Nov-2019 Early Stage VC 0000 Drug Discovery Startup 00000000 00000000 00.0
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Samsara BioCapital Exits (8)

To view Samsara BioCapital‘s complete exit history, request access »
Company Name Exit Date Exit Type Exit Size
Forma Therapeutics 19-Jun-2020 IPO 00000
00000000000 000000 13-Sep-2019 000 00000
000000 20-Jun-2019 000 00000
0000000 000000 18-Apr-2019 000 0000
00000 000000000 27-Sep-2018 000 0000
0000000 19-Jul-2018 000 00000
Odonate Therapeutics 07-Dec-2017 IPO 00000
Syros Pharmaceuticals Secondary Transaction - Open Market

Samsara BioCapital Team (4)

Name Title Deals Funds Boards Office
Srinivas Akkaraju Ph.D Founder & Managing General Partner 00 0 0 Palo Alto, CA
Michael Dybbs Ph.D Partner 00 0 0 Palo Alto, CA
Cory Freedland Ph.D Principal 0 0 0 Palo Alto, CA
Abraham Bassan Vice President Palo Alto, CA

Samsara BioCapital Co-Investors (94)

To view Samsara BioCapital‘s complete co-investor history, request access »
Name With Exits Lead Partner Series Industry
EcoR1 Capital 6 0 0 Series chart Industry bar
Redmile Group 0 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 0 Series chart Industry bar
The Invus Group 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar